Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 February 2020 | Story Lacea Loader

During meetings between the management of the University of the Free State (UFS) and the Bloemfontein Campus Student Representative Council (CSRC) the week of 27 January 2020, an agreement regarding accredited and non-accredited accommodation was reached. Although it has been communicated to students on the university’s campuses earlier this week, it is important to clarify the agreement: 

• For 2020, students on the three campuses of the UFS who receive funding from the National Student Financial Aid Scheme (NSFAS) and who live in accredited and non-accredited accommodation, will receive the monthly accommodation allowance that will be paid directly into the student’s bank account.  Please note that the matter of the lease agreement is between the student and the service provider and the UFS does not take responsibility for payments to any supplier. The payments will only be made once funds are received from NSFAS.  

• Registered NSFAS beneficiaries must log in on Self Service and apply online for the private accommodation allowance. The application process requires that the lease agreement should be uploaded on the Self-Service portal. This lease agreement must be signed by both the student and the service provider. 

• Approved private accommodation applicants will receive their private accommodation allowance payment during the first week of each month for a period of 10 months, depending on the date of approval and the rental period.

• If the service provider does not have a lease agreement, students can download a basic lease agreement form here. This form must be signed by the student and the service provider.

• A process will be in place to verify the accommodation during 2020, as required by the Department of Higher Education, Science and Technology (DHET).  This process will start with the completion of the application form for accreditation by the service provider.  The application form can be obtained here.



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept